Direxion Shares ETF Trust (PILL)
Management Company · ARCX · Series S000050532 · View on SEC EDGAR ↗
- Net assets
- $12.9M
- Holdings
- 65
- As of
- April 30, 2026 stale
- Top 10 holdings weight
- 40.83%
- Effective number of positions
- 19.8
- Positions above 1%
- 50
On this page
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Sector breakdown How the fund's holdings split across market sectors.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
Fund flows (SEC-reported)
- Last month (Apr 2026)
- -$557K
- Quarter ending Apr 2026
- -$5.8M
- Trailing 12 months
- -$9.4M
May 2025 – Apr 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 65 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| ESPERION THERAPEUTICS INC | 29664W105 | $128K | 1.00 | 64,147 | EC | US |
| CORMEDIX INC | 21900C308 | $123K | 0.95 | 16,200 | EC | US |
| Unknown security | — | $113K | 0.88 | 1 | DE | US |
| ARVINAS INC | 04335A105 | $105K | 0.81 | 10,582 | EC | US |
| BIOAGE LABS INC | 09077V100 | $104K | 0.81 | 6,165 | EC | US |
| ZEVRA THERAPEUTICS INC | 488445206 | $97K | 0.75 | 9,494 | EC | US |
| MAZE THERAPEUTICS INC | 578784100 | $91K | 0.71 | 3,421 | EC | US |
| SEPTERNA INC | 81734D104 | $89K | 0.69 | 3,760 | EC | US |
| WAVE LIFE SCIENCES LTD | Y95308105 | $87K | 0.67 | 12,254 | EC | SG |
| LB PHARMACEUTICALS INC | 50180M108 | $83K | 0.64 | 2,606 | EC | US |
| FULCRUM THERAPEUTICS INC | 359616109 | $77K | 0.59 | 10,748 | EC | US |
| AQUESTIVE THERAPEUTICS INC | 03843E104 | $72K | 0.56 | 17,545 | EC | US |
| ALTO NEUROSCIENCE INC | 02157Q109 | $55K | 0.43 | 2,143 | EC | US |
| Unknown security | — | $28K | 0.22 | 1 | DE | US |
| GOLDMAN SACHS LIQ ES FD A | — | $0 | 0.00 | 0 | STIV | US |
Sector breakdown
Institutional owners (13F) 8 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,348,938 | 69.77% | 74,692 | Shares | June 30, 2026 |
| GTS SECURITIES LLC | $458,543 | 23.72% | 25,390 | Shares | June 30, 2026 |
| Tower Research Capital LLC (TRC) | $105,163 | 5.44% | 5,823 | Shares | June 30, 2026 |
| UBS Group AG | $18,385 | 0.95% | 1,018 | Shares | June 30, 2026 |
| FINANCIAL CONSULATE, INC | $1,806 | 0.09% | 100 | Shares | June 30, 2026 |
| SIMPLEX TRADING, LLC | $397 | 0.02% | 22 | Shares | June 30, 2026 |
| MORGAN STANLEY | $38 | 0.00% | 2 | Shares | June 30, 2026 |
| AlphaMark Advisors, LLC | $7 | 0.00% | 1,000 | Shares | Dec. 31, 2024 |
Peer funds
More from this issuer
| Fund | AUM |
|---|---|
| SOXL Direxion Shares ETF Trust | $16.9B |
| SPXL Direxion Shares ETF Trust | $5.9B |
| TSLL Direxion Shares ETF Trust | $5.0B |
| TECL Direxion Shares ETF Trust | $4.7B |
| TMF Direxion Shares ETF Trust | $2.7B |
| FAS Direxion Shares ETF Trust | $2.0B |
| SOXS Direxion Shares ETF Trust | $1.9B |
| KORU Direxion Shares ETF Trust | $1.6B |
| TNA Direxion Shares ETF Trust | $1.5B |
| MUU Direxion Shares ETF Trust | $1.4B |
Similar by size
| Fund | AUM |
|---|---|
| MPLY Strategy Shares | $13.2M |
| EEMO Invesco Exchange-Traded Fund Tr… | $13.2M |
| SZNE Pacer Funds Trust | $13.4M |
| SNPG DBX ETF Trust | $13.4M |
| UXJA First Trust Exchange-Traded Fun… | $13.5M |
| SDCP Virtus ETF Trust II | $12.8M |
| EMIF iShares Trust | $12.8M |
| FARX Advisors' Inner Circle Fund II | $12.8M |
| EQLT iShares Trust | $12.7M |
| TYLG Global X Funds | $12.7M |